Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost/timolol eye drops in Chinese patients with open-angle glaucoma or ocular hypertension
CTR20150389Phase 4Active
- Sponsor
- AbbVie Inc.
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost + timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by AbbVie Inc.. Started Oct 2015; status: active.
02
Drugs
bimatoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on CTR20150389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150389.